Hepatitis A vaccine study for people with cirrhosis
Part of Digestive system clinical trials.
This study checks whether a single dose of the hepatitis A vaccine helps protect people with cirrhosis who have no immunity. It aims to see how well the vaccine works and your body's response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (serious liver scarring).
- You have no immunity to hepatitis A (a liver infection).
- You have never received a hepatitis A vaccine.
- You are not pregnant and are stable enough to take part.
- You are willing to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the types of germs (bacteria or viruses) that cause infections in people who have cirrhosis from Hepatitis B. The goal is to learn which germs are common, so doctors can better treat or prevent such infections in the future.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
This study tests a new vaccine designed to prevent hepatitis C, a virus that affects the liver. The goal is to see if the vaccine is safe, and to understand how the body's immune system responds to it.
This study compares giving the hepatitis B vaccine in 2 doses versus 3 doses for people with cirrhosis who do not yet have protection against hepatitis B. It may help your care team choose the schedule most likely to build lasting immunity.
This study is looking at how the immune system responds in children with acute hepatitis A (a liver infection). Participation may help doctors better understand the body's natural defenses and improve care for other children.
This study tests a vaccine strategy for people who are being evaluated and waiting for a liver transplant. The goal is to see how well the immune system responds and how the results are interpreted before transplant.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.